Neuca
-13.23%

Pharma / Pharmaceuticals and Distribution

🚀 Founded 1990 🌎 Poland 🏷️ NEU.WA PLTRFRM00018 ⭐ 1000

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (2) 🏢 Company Q&A (663) 🛠️ Industry Q&A (164) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

🔄 Cash Flow ⚖️ Balance Sheet 💵 Income Statement 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

🔥 Video Insights

[Disclaimer]

Why Is Neuca’s Stock So Cheap Right Now? Here’s What the Market Might Be Missing

July 17, 2025

Neuca’s stock is trading at a surprisingly low level — but is the market overlooking something? In this video, we break down Neuca’s business model, financials, dividend history, risks, and why some investors might want to take a second look. No hype, just clear value insight. For more deep-dive reviews like this one, visit InsightfulValue.com

Hidden Gem in Healthcare? Neuca’s Stock Is Down — Is It a Smart Buy Now?

June 5, 2025

Neuca is a leader in pharmaceutical distribution and healthcare services in Poland, but its stock has been slipping. In this video, we take a closer look at whether this price drop is a buying opportunity or a sign of trouble. We break down Neuca’s business model, financials, and risks to help you make sense of this undervalued stock. For more insights, visit InsightfulValue.com.

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.